Identification of a core member of the SWI/SNF complex, BAF155/SMARCC1, as a human tumor suppressor gene

Jessica del Bove, Gary Rosson, Matthew Strobeck, Jianguang Chen, Trevor K. Archer, Weidong Wang, Erik S. Knudsen, Bernard E. Weissman

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Recent studies have established that two core members of the SWI/SNF chromatin remodeling complex, BRG1 and SNF5/INI1, possess tumor-uppressor activity in human and mouse cancers. While the third core member, BAF155, has been implicated by several studies as having a potential role in tumor development, direct evidence for its tumor suppressor activity has remained lacking. Therefore, we screened for BAF155 deficiency in a large number of human tumor cell lines. We identified two cell lines, the SNUC2B colon carcinoma and the SKOV3 ovarian carcinoma, displaying a complete loss of protein expression while maintaining normal levels of mRNA expression. The SKOV3 cell line possesses a heterozygous 4 bp deletion that results in an 855AA truncated protein, while the cause of the loss of BAF155 expression in the SNUC2B cell line appears due to a post-transcriptional error. However, the lack of detectable BAF155 expression did not affect sensitivity to RB-mediated cell cycle arrest. Re-expression of full length but not a truncated form of BAF155 in the two cancer cell lines leads to reduced colony forming ability characterized by replicative senescence but not apoptosis. Collectively, these data suggest that loss of BAF155 expression represents another mechanism for inactivation of SWI/SNF complex activity in the development in human cancer. Our results further indicate that the c-terminus proline-glutamine rich domain plays a critical role in the tumor suppressor activity of this protein.

Original languageEnglish (US)
Pages (from-to)1444-1453
Number of pages10
JournalEpigenetics
Volume6
Issue number12
DOIs
StatePublished - 2011

Fingerprint

Tumor Suppressor Genes
Cell Line
Neoplasms
Carcinoma
Tumor Suppressor Proteins
Aptitude
Chromatin Assembly and Disassembly
Cell Aging
Human Development
Cell Cycle Checkpoints
Tumor Cell Line
Glutamine
Proline
Human Activities
Colon
Proteins
Apoptosis
Messenger RNA

Keywords

  • BAF155
  • Cancer epigenetics
  • SMARCC1
  • SWI/SNF
  • Tumor suppressor gene

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research

Cite this

del Bove, J., Rosson, G., Strobeck, M., Chen, J., Archer, T. K., Wang, W., ... Weissman, B. E. (2011). Identification of a core member of the SWI/SNF complex, BAF155/SMARCC1, as a human tumor suppressor gene. Epigenetics, 6(12), 1444-1453. https://doi.org/10.4161/epi.6.12.18492

Identification of a core member of the SWI/SNF complex, BAF155/SMARCC1, as a human tumor suppressor gene. / del Bove, Jessica; Rosson, Gary; Strobeck, Matthew; Chen, Jianguang; Archer, Trevor K.; Wang, Weidong; Knudsen, Erik S.; Weissman, Bernard E.

In: Epigenetics, Vol. 6, No. 12, 2011, p. 1444-1453.

Research output: Contribution to journalArticle

del Bove, J, Rosson, G, Strobeck, M, Chen, J, Archer, TK, Wang, W, Knudsen, ES & Weissman, BE 2011, 'Identification of a core member of the SWI/SNF complex, BAF155/SMARCC1, as a human tumor suppressor gene', Epigenetics, vol. 6, no. 12, pp. 1444-1453. https://doi.org/10.4161/epi.6.12.18492
del Bove, Jessica ; Rosson, Gary ; Strobeck, Matthew ; Chen, Jianguang ; Archer, Trevor K. ; Wang, Weidong ; Knudsen, Erik S. ; Weissman, Bernard E. / Identification of a core member of the SWI/SNF complex, BAF155/SMARCC1, as a human tumor suppressor gene. In: Epigenetics. 2011 ; Vol. 6, No. 12. pp. 1444-1453.
@article{bda06ef0acad42c797a8ca9b0f9c2901,
title = "Identification of a core member of the SWI/SNF complex, BAF155/SMARCC1, as a human tumor suppressor gene",
abstract = "Recent studies have established that two core members of the SWI/SNF chromatin remodeling complex, BRG1 and SNF5/INI1, possess tumor-uppressor activity in human and mouse cancers. While the third core member, BAF155, has been implicated by several studies as having a potential role in tumor development, direct evidence for its tumor suppressor activity has remained lacking. Therefore, we screened for BAF155 deficiency in a large number of human tumor cell lines. We identified two cell lines, the SNUC2B colon carcinoma and the SKOV3 ovarian carcinoma, displaying a complete loss of protein expression while maintaining normal levels of mRNA expression. The SKOV3 cell line possesses a heterozygous 4 bp deletion that results in an 855AA truncated protein, while the cause of the loss of BAF155 expression in the SNUC2B cell line appears due to a post-transcriptional error. However, the lack of detectable BAF155 expression did not affect sensitivity to RB-mediated cell cycle arrest. Re-expression of full length but not a truncated form of BAF155 in the two cancer cell lines leads to reduced colony forming ability characterized by replicative senescence but not apoptosis. Collectively, these data suggest that loss of BAF155 expression represents another mechanism for inactivation of SWI/SNF complex activity in the development in human cancer. Our results further indicate that the c-terminus proline-glutamine rich domain plays a critical role in the tumor suppressor activity of this protein.",
keywords = "BAF155, Cancer epigenetics, SMARCC1, SWI/SNF, Tumor suppressor gene",
author = "{del Bove}, Jessica and Gary Rosson and Matthew Strobeck and Jianguang Chen and Archer, {Trevor K.} and Weidong Wang and Knudsen, {Erik S.} and Weissman, {Bernard E.}",
year = "2011",
doi = "10.4161/epi.6.12.18492",
language = "English (US)",
volume = "6",
pages = "1444--1453",
journal = "Epigenetics",
issn = "1559-2294",
publisher = "Landes Bioscience",
number = "12",

}

TY - JOUR

T1 - Identification of a core member of the SWI/SNF complex, BAF155/SMARCC1, as a human tumor suppressor gene

AU - del Bove, Jessica

AU - Rosson, Gary

AU - Strobeck, Matthew

AU - Chen, Jianguang

AU - Archer, Trevor K.

AU - Wang, Weidong

AU - Knudsen, Erik S.

AU - Weissman, Bernard E.

PY - 2011

Y1 - 2011

N2 - Recent studies have established that two core members of the SWI/SNF chromatin remodeling complex, BRG1 and SNF5/INI1, possess tumor-uppressor activity in human and mouse cancers. While the third core member, BAF155, has been implicated by several studies as having a potential role in tumor development, direct evidence for its tumor suppressor activity has remained lacking. Therefore, we screened for BAF155 deficiency in a large number of human tumor cell lines. We identified two cell lines, the SNUC2B colon carcinoma and the SKOV3 ovarian carcinoma, displaying a complete loss of protein expression while maintaining normal levels of mRNA expression. The SKOV3 cell line possesses a heterozygous 4 bp deletion that results in an 855AA truncated protein, while the cause of the loss of BAF155 expression in the SNUC2B cell line appears due to a post-transcriptional error. However, the lack of detectable BAF155 expression did not affect sensitivity to RB-mediated cell cycle arrest. Re-expression of full length but not a truncated form of BAF155 in the two cancer cell lines leads to reduced colony forming ability characterized by replicative senescence but not apoptosis. Collectively, these data suggest that loss of BAF155 expression represents another mechanism for inactivation of SWI/SNF complex activity in the development in human cancer. Our results further indicate that the c-terminus proline-glutamine rich domain plays a critical role in the tumor suppressor activity of this protein.

AB - Recent studies have established that two core members of the SWI/SNF chromatin remodeling complex, BRG1 and SNF5/INI1, possess tumor-uppressor activity in human and mouse cancers. While the third core member, BAF155, has been implicated by several studies as having a potential role in tumor development, direct evidence for its tumor suppressor activity has remained lacking. Therefore, we screened for BAF155 deficiency in a large number of human tumor cell lines. We identified two cell lines, the SNUC2B colon carcinoma and the SKOV3 ovarian carcinoma, displaying a complete loss of protein expression while maintaining normal levels of mRNA expression. The SKOV3 cell line possesses a heterozygous 4 bp deletion that results in an 855AA truncated protein, while the cause of the loss of BAF155 expression in the SNUC2B cell line appears due to a post-transcriptional error. However, the lack of detectable BAF155 expression did not affect sensitivity to RB-mediated cell cycle arrest. Re-expression of full length but not a truncated form of BAF155 in the two cancer cell lines leads to reduced colony forming ability characterized by replicative senescence but not apoptosis. Collectively, these data suggest that loss of BAF155 expression represents another mechanism for inactivation of SWI/SNF complex activity in the development in human cancer. Our results further indicate that the c-terminus proline-glutamine rich domain plays a critical role in the tumor suppressor activity of this protein.

KW - BAF155

KW - Cancer epigenetics

KW - SMARCC1

KW - SWI/SNF

KW - Tumor suppressor gene

UR - http://www.scopus.com/inward/record.url?scp=83255184470&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83255184470&partnerID=8YFLogxK

U2 - 10.4161/epi.6.12.18492

DO - 10.4161/epi.6.12.18492

M3 - Article

C2 - 22139574

AN - SCOPUS:83255184470

VL - 6

SP - 1444

EP - 1453

JO - Epigenetics

JF - Epigenetics

SN - 1559-2294

IS - 12

ER -